Regional Business Manager - NYC
Intellia Therapeutics, Inc.
July 01, 2026
On-site
Cambridge, MA
Sales
How You Will Achieve More
Sales Representative (Commercial Launch) for in vivo CRISPR therapy for hereditary angioedema (HAE). Territory: Long Island, NY.
Responsibilities
- Develop and execute comprehensive territory plans targeting immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers.
- Identify and prioritize high-value accounts based on HAE patient volume, prescriber influence, and institutional capabilities.
- Build trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makers.
- Maintain a robust sales pipeline from initial awareness through patient treatment completion.
- Educate healthcare providers on in vivo CRISPR gene editing mechanisms and differentiate from ex vivo therapies/traditional treatments.
- Articulate MOA differentiation vs prophylactic treatments, complement inhibitors, and plasma-derived therapies.
- Present Phase III efficacy and safety data.
- Address CRISPR safety misconceptions and differentiate from previous gene therapy launches.
- Educate on unmet needs and disease management/treatment burden.
- Maintain competitive intelligence and communicate differentiated value propositions.
- Handle objections regarding CRISPR tech, permanent genetic modification, and single-treatment cost.
- Educate on patient pathway from diagnosis confirmation through treatment administration.
- Coordinate with patient support hubs to ensure seamless patient experience and access.
- Partner with Medical Science Liaisons, Field Reimbursement Managers, and the strategic accounts team.
Qualifications
- Comprehensive knowledge of HAE pathophysiology, treatment landscape, and unmet medical needs.
- Understanding of gene editing technologies, genetic medicines, and regulatory requirements.
- Ability to analyze and present complex clinical trial data and real-world evidence.
- Exceptional ability to communicate complex scientific concepts to diverse healthcare audiences.
- Proven ability to build and maintain long-term stakeholder relationships.
- Creative problem solving to overcome access barriers and implementation challenges.
- Business-owner mindset; develops and executes comprehensive business plans.
- BS/BA in life sciences or a business-related field.
- Rare disease/gene therapy/HAE market knowledge preferred.
- 5+ years specialty pharmaceutical sales experience (preferably rare diseases, immunology, or genetic medicines).
- Proven rare disease commercialization experience.
- Product launch experience (first-in-class/novel mechanism preferred).
- Success in 12–18 month long sales cycles with multiple stakeholders.
Application instructions
Applications accepted on a rolling basis until the position is filled.
Sales Representative (Commercial Launch) for in vivo CRISPR therapy for hereditary angioedema (HAE). Territory: Long Island, NY.
Responsibilities
- Develop and execute comprehensive territory plans targeting immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers.
- Identify and prioritize high-value accounts based on HAE patient volume, prescriber influence, and institutional capabilities.
- Build trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makers.
- Maintain a robust sales pipeline from initial awareness through patient treatment completion.
- Educate healthcare providers on in vivo CRISPR gene editing mechanisms and differentiate from ex vivo therapies/traditional treatments.
- Articulate MOA differentiation vs prophylactic treatments, complement inhibitors, and plasma-derived therapies.
- Present Phase III efficacy and safety data.
- Address CRISPR safety misconceptions and differentiate from previous gene therapy launches.
- Educate on unmet needs and disease management/treatment burden.
- Maintain competitive intelligence and communicate differentiated value propositions.
- Handle objections regarding CRISPR tech, permanent genetic modification, and single-treatment cost.
- Educate on patient pathway from diagnosis confirmation through treatment administration.
- Coordinate with patient support hubs to ensure seamless patient experience and access.
- Partner with Medical Science Liaisons, Field Reimbursement Managers, and the strategic accounts team.
Qualifications
- Comprehensive knowledge of HAE pathophysiology, treatment landscape, and unmet medical needs.
- Understanding of gene editing technologies, genetic medicines, and regulatory requirements.
- Ability to analyze and present complex clinical trial data and real-world evidence.
- Exceptional ability to communicate complex scientific concepts to diverse healthcare audiences.
- Proven ability to build and maintain long-term stakeholder relationships.
- Creative problem solving to overcome access barriers and implementation challenges.
- Business-owner mindset; develops and executes comprehensive business plans.
- BS/BA in life sciences or a business-related field.
- Rare disease/gene therapy/HAE market knowledge preferred.
- 5+ years specialty pharmaceutical sales experience (preferably rare diseases, immunology, or genetic medicines).
- Proven rare disease commercialization experience.
- Product launch experience (first-in-class/novel mechanism preferred).
- Success in 12–18 month long sales cycles with multiple stakeholders.
Application instructions
Applications accepted on a rolling basis until the position is filled.